Labeler
AvKARE NDC Codes
AvKARE lists 374 finished drug products in the FDA NDC Directory under NDC labeler codes 42291, 73190.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dasatinib, Lisdexamfetamine Dimesylate, Amlodipine Besylate and Benazepril Hydrochloride, brivaracetam, Eltrombopag Olamine, Deflazacort, Tacrolimus, Tapentadol Hydrochloride, Tofacitinib, Famciclovir, olmesartan medoxomil-hydrochlorothiazide, Sacubitril and Valsartan, Risperidone, Verapamil Hydrochloride, Mirabegron
- Active ingredients
- Dasatinib, Lisdexamfetamine dimesylate, Amlodipine besylate, Benazepril hydrochloride, Brivaracetam, Eltrombopag olamine, Deflazacort, Tacrolimus, Tapentadol hydrochloride, Tofacitinib citrate, Famciclovir, Olmesartan medoxomil
- NDC labeler codes
- 42291, 73190
- Strengths (from the 100 most recently listed products)
- Benazepril hydrochloride 10 mg/1; Benazepril hydrochloride 20 mg/1; Amlodipine besylate 5 mg/1; Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1; Metaxalone 800 mg/1; Tacrolimus .5 mg/1; Tacrolimus 1 mg/1; Tacrolimus 5 mg/1; Verapamil hydrochloride 120 mg/1; Verapamil hydrochloride 80 mg/1; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Amlodipine besylate 2.5 mg/1; Amlodipine besylate 10 mg/1; Dutasteride .5 mg/1; Tapentadol hydrochloride 75 mg/1; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 100 mg/1; Lacosamide 10 mg/mL
- Dosage forms
- Tablet, Film coated, Capsule, Tablet, Tablet, Orally disintegrating, Tablet, Film coated, Extended release, Capsule, Extended release, Solution, Suspension, Tablet, Extended release
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, Calcium Channel Blocker, Angiotensin 2 Receptor Blocker, Central Nervous System Stimulant, Angiotensin Converting Enzyme Inhibitor, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Corticosteroid, Serotonin-3 Receptor Antagonist, Calcineurin Inhibitor Immunosuppressant, Opioid Agonist, Janus Kinase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Thiazide Diuretic, Neprilysin Inhibitor, Atypical Antipsychotic, beta3-Adrenergic Agonist, Iron Chelator, Phosphodiesterase 4 Inhibitor, Thyroid Hormone Synthesis Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor, Cephalosporin Antibacterial, Muscle Relaxant, Serotonin Reuptake Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Progesterone, Phosphate Binder, Serotonin-1b and Serotonin-1d Receptor Agonist, Phosphodiesterase 5 Inhibitor, Serotonin-4 Receptor Agonist, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, 5-alpha Reductase Inhibitor, Influenza A M2 Protein Inhibitor, Antimalarial, Antiprotozoal, Sulfone, alpha-Adrenergic Blocker, P2Y12 Platelet Inhibitor, Tetracycline-class Drug, Osmotic Laxative, Potassium Salt, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Blood Coagulation Factor, Cholinergic Muscarinic Antagonist, Antimetabolite Immunosuppressant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 117 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | 42291-986 | 42291-0986-01 | — |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | 42291-987 | 42291-0987-01 | — |
| Tacrolimus | Tacrolimus 5 mg/1 | CapsuleOral | 42291-990 | 42291-0990-01 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 120 mg/1 | Tablet, Film coatedOral | 73190-107 | 73190-0107-01 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 80 mg/1 | Tablet, Film coatedOral | 73190-106 | 73190-0106-01 | — |
| Mirabegron | Mirabegron 25 mg/1 | Tablet, Film coated, Extended releaseOral | 73190-115 | 73190-0115-3073190-0115-90 | — |
| Mirabegron | Mirabegron 50 mg/1 | Tablet, Film coated, Extended releaseOral | 73190-116 | 73190-0116-3073190-0116-90 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 2.5 mg/1; Benazepril hydrochloride 10 mg/1 | CapsuleOral | 73190-020 | 73190-0020-01 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 10 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 73190-024 | 73190-0024-01 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 10 mg/1 | CapsuleOral | 73190-021 | 73190-0021-01 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 73190-022 | 73190-0022-01 | — |
| Dutasteride | Dutasteride .5 mg/1 | CapsuleOral | 42291-257 | 42291-0257-3042291-0257-90 | — |
| Tapentadol Hydrochloride | Tapentadol hydrochloride 75 mg/1 | Tablet, Film coatedOral | 73190-082 | 73190-0082-01 | — |
| Tapentadol Hydrochloride | Tapentadol hydrochloride 50 mg/1 | Tablet, Film coatedOral | 73190-081 | 73190-0081-01 | — |
| Tapentadol Hydrochloride | Tapentadol hydrochloride 100 mg/1 | Tablet, Film coatedOral | 73190-083 | 73190-0083-01 | — |
| Lacosamide Oral Solutionlacosamide | Lacosamide 10 mg/mL | SolutionOral | 73190-103 | 73190-0103-20 | — |
| Deferiprone | Deferiprone 500 mg/1 | TabletOral | 73190-095 | 73190-0095-01 | — |
| Tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | 73190-101 | 73190-0101-60 | — |
| Tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | 73190-100 | 73190-0100-60 | — |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | 73190-093 | 73190-0093-30 | — |
| Famciclovir | Famciclovir 125 mg/1 | Tablet, Film coatedOral | 73190-091 | 73190-0091-30 | — |
| Famciclovir | Famciclovir 250 mg/1 | Tablet, Film coatedOral | 73190-092 | 73190-0092-30 | — |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | 73190-096 | 73190-0096-60 | — |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | 73190-097 | 73190-0097-60 | — |
| olmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 73190-080 | 73190-0080-90 | — |
| olmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 73190-079 | 73190-0079-90 | — |
| olmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 73190-078 | 73190-0078-90 | — |
| roflumilast | Roflumilast 500 ug/1 | TabletOral | 73190-087 | 73190-0087-3073190-0087-90 | — |
| Tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 73190-102 | 73190-0102-30 | — |
| roflumilast | Roflumilast 250 ug/1 | TabletOral | 73190-086 | 73190-0086-28 | — |
| amantadine hydrochloride | Amantadine hydrochloride 100 mg/1 | CapsuleOral | 73190-094 | 73190-0094-50 | — |
| Methimazole | Methimazole 5 mg/1 | TabletOral | 73190-084 | 73190-0084-01 | — |
| Methimazole | Methimazole 10 mg/1 | TabletOral | 73190-085 | 73190-0085-01 | — |
| Atovaquone | Atovaquone 750 mg/5mL | SuspensionOral | 73190-098 | 73190-0098-21 | — |
| Dapagliflozin | Dapagliflozin 5 mg/1 | Tablet, Film coatedOral | 73190-072 | 73190-0072-3073190-0072-90 | — |
| Dapagliflozin | Dapagliflozin 10 mg/1 | Tablet, Film coatedOral | 73190-073 | 73190-0073-3073190-0073-90 | — |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | 73190-075 | 73190-0075-60 | — |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | 73190-074 | 73190-0074-60 | — |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | 73190-076 | 73190-0076-60 | — |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | 73190-077 | 73190-0077-60 | — |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | 42291-007 | 42291-0007-50 | — |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | 42291-006 | 42291-0006-50 | — |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | 42291-985 | 42291-0985-01 | — |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | 42291-985 | 42291-0985-50 | — |
| nilotinib | Nilotinib 150 mg/1 | CapsuleOral | 73190-033 | 73190-0033-1173190-0033-12 | — |
| nilotinib | Nilotinib 200 mg/1 | CapsuleOral | 73190-034 | 73190-0034-1173190-0034-12 | — |
| Eltrombopag Olamineeltrombopag | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | 42291-934 | 42291-0934-30 | — |
| Eltrombopag Olamineeltrombopag | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | 42291-932 | 42291-0932-30 | — |
| Eltrombopag Olamineeltrombopag | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | 42291-933 | 42291-0933-30 | — |
| Eltrombopag Olamineeltrombopag | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | 42291-935 | 42291-0935-30 | — |
AvKARE: common questions
- What is AvKARE's NDC labeler code?
- 42291, 73190. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AvKARE?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.